Kamada Ltd (KMDA)
5.10
+0.05
(+0.99%)
USD |
NASDAQ |
Apr 22, 16:00
5.19
+0.09
(+1.76%)
After-Hours: 20:00
Kamada Enterprise Value: 237.50M for April 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 22, 2024 | 237.50M |
| April 19, 2024 | 234.63M |
| April 18, 2024 | 237.50M |
| April 17, 2024 | 236.35M |
| April 16, 2024 | 226.01M |
| April 15, 2024 | 238.65M |
| April 12, 2024 | 239.80M |
| April 11, 2024 | 243.25M |
| April 10, 2024 | 247.28M |
| April 09, 2024 | 249.00M |
| April 08, 2024 | 255.90M |
| April 05, 2024 | 253.60M |
| April 04, 2024 | 250.72M |
| April 03, 2024 | 266.24M |
| April 02, 2024 | 263.94M |
| April 01, 2024 | 266.82M |
| March 28, 2024 | 266.82M |
| March 27, 2024 | 266.24M |
| March 26, 2024 | 265.67M |
| March 25, 2024 | 273.72M |
| March 22, 2024 | 273.72M |
| March 21, 2024 | 277.74M |
| March 20, 2024 | 281.76M |
| March 19, 2024 | 274.29M |
| March 18, 2024 | 281.76M |
| Date | Value |
|---|---|
| March 15, 2024 | 266.24M |
| March 14, 2024 | 265.09M |
| March 13, 2024 | 273.14M |
| March 12, 2024 | 277.17M |
| March 11, 2024 | 272.57M |
| March 08, 2024 | 292.11M |
| March 07, 2024 | 300.73M |
| March 06, 2024 | 292.11M |
| March 05, 2024 | 310.50M |
| March 04, 2024 | 313.38M |
| March 01, 2024 | 310.50M |
| February 29, 2024 | 306.48M |
| February 28, 2024 | 304.18M |
| February 27, 2024 | 312.23M |
| February 26, 2024 | 296.13M |
| February 23, 2024 | 297.86M |
| February 22, 2024 | 302.46M |
| February 21, 2024 | 289.81M |
| February 20, 2024 | 292.40M |
| February 16, 2024 | 296.71M |
| February 15, 2024 | 297.28M |
| February 14, 2024 | 289.81M |
| February 13, 2024 | 284.06M |
| February 12, 2024 | 289.81M |
| February 09, 2024 | 288.66M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
129.87M
Minimum
Mar 17 2020
418.09M
Maximum
Aug 24 2020
209.40M
Average
200.10M
Median
May 31 2022
Enterprise Value Benchmarks
| Compugen Ltd | 118.53M |
| Pluri Inc | 22.19M |
| BioLine Rx Ltd | 20.91M |
| Can Fite Biofarma Ltd | 0.959M |
| BiomX Inc | 12.58M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 5.058M |
| Revenue (Quarterly) | 36.43M |
| Total Expenses (Quarterly) | 33.66M |
| EPS Diluted (Quarterly) | 0.09 |
| Gross Profit Margin (Quarterly) | 39.56% |
| Profit Margin (Quarterly) | 13.88% |
| Earnings Yield | 2.94% |
| Operating Earnings Yield | 3.92% |
| Normalized Earnings Yield | 2.862 |